NCT02459886View on ClinicalTrials.gov

Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

November 20, 2017

Study Completion Date

November 20, 2017

Conditions
Parkinson's DiseaseHealthy
Interventions
DRUG

BIIB054

IV infusion

DRUG

Placebo

IV infusion

Trial Locations (9)

20007

Research Site, Washington D.C.

27705

Research Site, Durham

33009

Research Site, Hallandale

44195

Research Site, Cleveland

47710

Research Site, Evansville

48334

Research Site, Farmington Hills

75247

Research Site, Dallas

99202

Research Site, Spokane

32765-4515

Research Site, Oviedo

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY